MAPS Congratulates Lykos Therapeutics on Acceptance of New :

The FDA has accepted Lykos Therapeutics' New Drug Application, supported by two decades of research incubated by MAPS, for MDMA-assisted therapy for PTSD....

Related Keywords

Rick Doblin , Public Benefit Corporation , Drug Administration , Multidisciplinary Association For Psychedelic , New Drug Application , Lykos Therapeutics , Priority Review , Multidisciplinary Association , Psychedelic Studies , Benefit Corporation , Prescription Drug User Fee Act , Zendo Project , Multidisciplinary Association For Psychedelic Studies Maps , Dma , Mdma Assisted Therapy , Psychedelics , Psychedelic Assisted Therapy , Ptsd ,